- Product
- Comedian Kim Chulmin, doesn’t recommend taking Fenbendazole
- by Kim, Min-Gun Sep 24, 2020 06:20am
- Comedian Kim Chulmin, who aroused hope by taking animal repellent 'Fenbendazole' for anticancer purposes, said, "I will never go back because my condition has deteriorated. I don't want to recommend it to my family." He said that it was over. In an interview with CBS' Kim Hyun-jung's NEWS SHOW on the morning of the 22nd, Kim, who is strugglin
- Product
- Pharmacies rage on non-refundable price-reduced drug
- by Jung, Heung-Jun Sep 23, 2020 06:21am
- The pricings of four doses of Novartis’ immunosuppressant Certican have been brought down by 30 percent as of Sept. 20, and pharmacies are outraged with the pharmaceutical company refusing to refund the single tablets. Pharmacists are questioning the company’s refund policy as it would solely burden the pharmacies with the differences m
- Product
- “MA and marketer need experience, analytic mind, acumen”
- by Kim, Min-Gun Sep 18, 2020 06:29am
- “For a Market Access (MA) specialist, the most important skill set is to analyze the clinical trial data and to recreate them as a valuable message. They need to find any missing data required for pharmaceutical reimbursement review, and prepare the evidences prior to the review, if need be. If you are a pharmacy school student and want to beco
- Product
- 10,000 pros & cons for generic substitution
- by Kim, Min-Gun Sep 10, 2020 06:23am
- There are a lot of unusual comments in the National Assembly legislation, where not even a single comment is usually posted. These are the 'Simplification Act for Generic Substitution Post Notification' and 'The Act on Restriction of 1+3 Joint Biological Equivalence'. All of them are laws related to the issue of generc prescription. Among the
- Product
- Halted fight between government vs. doctors damages both
- by Kang, Shin-Kook Sep 9, 2020 05:46am
- The Korean Medical Association (KMA) has decided to temporarily halt but revisit their discussion with the government and the ruling party on increasing the quota for medical school and establishing public medical school, until COVID-19 is contained. The junior doctors are most likely to return for their duty after the last discussion on Sept. 7
- Product
- Successful August KMA strike all depends on participation
- by Kang, Shin-Kook Aug 3, 2020 11:05am
- The doctors’ organization objecting against the South Korean government intending to expand medical school admission and provide coverage on Korean herbal medicine are drawing up a plan to call a private clinic doctors’ strike. The strike is most likely to be on Aug. 14. According to Korean Medical Association (KMA) on July 29, the issue o
- Product
- Eventually, Fulcare’s YouTube Ad is deleted
- by Jung, Heung-Jun Jul 20, 2020 06:18am
- When Mennarini Korea's athlete's foot drug Fulcare’s YouTube advertisement raised a problem saying that Ads excluded pharmacist skills, the pharmaceutical company deleted the video and began to rectify it. The content of the controversial advertisement is a scene where Another patient who was waiting for a patient who visited the pharmac
- Product
- Will electronic masks by LG be commercialized?
- by Kang, Shin-Kook Jul 15, 2020 06:33am
- Electronic masks made by famous domestic home appliance companies are attracting attention. LG Electronics announced on the 12th that it has donated 2000 electronic masks made of electronics and IT technology to Severance Hospital to express appreciation and support to medical staff who need to work while wearing masks to overcome COVID-19.
- Product
- Why Tylenol short in pharmacy, but still plenty in GS25?
- by Jung, Heung-Jun Jun 18, 2020 06:27am
- Pharmacies in Korea are experiencing a long-term shortage of Tylenol 500 mg and Tylenol ER 600 mg, but apparently convenient stores have no issue stocking up Tylenol 500 mg. As of June 15, Tylenol in 500 mg and ER 650 mg tablets were indicated to be sold out on an online pharmaceutical wholesale website used by pharmacists. Since the
- Product
- Metformin's alternative medicine sold out in an hour
- by Kim JiEun May 29, 2020 06:16am
- As the discontinuation of sales of 31 items of Metformin used as a treatment for type II diabetes patients is decided, the shortage of alternative products is intensifying. The MFDS announced that it will temporarily manufacture, sell, and discontinue prescriptions for 31 items containing Metformin, which are used as a primary treatment for t
